This article first appeared on GuruFocus .
Release Date: January 28, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Sagility Ltd ( NSE:SAGILITY ) reported a strong year-on-year revenue growth of 35.7% in INR and 29.1% in constant currency for Q3.
-
The company's operating profits showed strength with an adjusted EBITDA growth of 24.2% year-on-year, maintaining a robust margin of 26%.
-
Sagility Ltd ( NSE:SAGILITY ) successfully expanded its clinical operation footprint for a large payer client, demonstrating growth within existing relationships.
-
The acquisition of BroadPath has increased the company's exposure to open enrollment-related work, contributing to a projected increase in seasonal revenues.
-
The company has been recognized for its innovation and excellence in healthcare, earning accolades such as the Ecovadis committed badge for sustainability and being named among India's best workplaces in pharmaceuticals, healthcare, and biotech.
Negative Points
-
The ACA subsidy expiration has resulted in a decline of roughly 3.4% in enrollments, although Sagility Ltd ( NSE:SAGILITY ) has minimal exposure to this market.
-
There is ongoing pressure on margins due to higher shares of revenues coming from less profitable locations, despite strong revenue growth.
-
The company's net new ACV saw a slight drop this quarter, attributed to the seasonal nature of the business and the focus on open enrollment activities.
-
There is a constant pressure from clients for cost reductions and efficiency improvements, which could impact profitability.
-
The integration of BroadPath is still ongoing, with synergies expected to play out over the next 2 to 3 years, indicating potential delays in realizing full benefits.
Q & A Highlights
-
Warning! GuruFocus has detected 2 Warning Sign with BOM:543663.
-
Is NSE:SAGILITY fairly valued? Test your thesis with our free DCF calculator.
Q: Could you explain the impact of open enrollment on your revenue and how it affects Q4? Also, why have margins remained stable despite strong revenue growth? A: The performance was strong across both our traditional large clients and BroadPath. The seasonality of open enrollment (OE) is a known factor, and it used to account for about 3% of our revenues, which has increased to 5.5% this year due to exceptional performance. Regarding margins, while we benefited from stronger Forex and operating leverage, a higher share of revenues came from less profitable locations, which balanced out the margin profile. - Ramesh Gopalan, Managing Director and Group CEO; Abhishek Kyyan, Deputy CFO
Q: What strategies are in place to diversify revenue beyond the top 10 clients? A: We are focused on expanding into mid and small market segments, which has been a priority for over three years. While top clients continue to grow, we are consistently increasing the number of new logos in smaller market segments. Our strategy includes mining additional white spaces in larger clients and expanding our clinical operation footprint. - Ramesh Gopalan, Managing Director and Group CEO
Q: How is Sagility positioned to capture greater market share through outcome-based engagements? A: We are building on our domain expertise and transformation capabilities. Outcome-driven models involve contracts where clients expect cost reductions over several years, achieved through technology and transformation. We have partnered with technology vendors to offer end-to-end services, managing both technology and related services. This approach is evolving, and we plan to launch more offerings leveraging partner capabilities. - Ramesh Gopalan, Managing Director and Group CEO
Q: With the potential slashing of Medicare Advantage funding, will there be an immediate adverse impact on volumes or enrollments? A: The membership for 2026 was decided through the recent AEP, so there will be no immediate impact on membership or rates. The announced rates are for calendar year 2027, and we are awaiting final numbers. Therefore, there is no immediate adverse impact expected. - Ramesh Gopalan, Managing Director and Group CEO
Q: How does Sagility plan to manage potential margin pressures given the current high margin profile? A: There is always margin pressure, especially during times of heightened profitability concerns at our clients' end. We aim to deliver cost reductions for clients while maintaining our margins through productivity improvements, technology, and transformation. We are confident in managing these pressures and maintaining our guidance. - Ramesh Gopalan, Managing Director and Group CEO
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
